Janux Therapeutics, Inc. (NASDAQ:JANX) Receives $89.90 Consensus PT from Analysts
Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) has been assigned a consensus recommendation of “Buy” from the twelve brokerages that are currently covering the company, MarketBeat reports. One research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the […]
28 Dec 10:06 · The Markets Daily